Scholarlink

<p>The blood-testis barrier is essential for sperm development but also blocks the delivery of non-hormonal male contraceptives and other germ-cell-targeting therapies. However, how this barrier opens and closes in a controlled manner remains poorly understood. Here we show that the barrier exhibits time-of-day-dependent changes in permeability, allowing drugs to enter selectively during the light phase while remaining sealed during the dark phase. This gating mechanism is driven by daily fluctuations in testosterone. When testosterone rises at night, it activates calcium channels in supporting cells of the testis, leading to dephosphorylation of a key scaffolding protein called zonula occludens-1. This triggers the protein to undergo liquid-liquid phase separation, forming condensates that tighten the barrier. During the day, when testosterone drops, the condensates dissolve and the barrier becomes more permeable. Manipulating this calcium pathway pharmacologically enhances the entry of a contraceptive candidate without causing permanent toxicity. A specific disordered region within zonula occludens-1 is identified as the core driver of this testosterone-responsive condensation. Our study establishes diurnal hormone oscillations as a physiological rheostat for biomolecular condensate formation, offering a chronotherapeutic strategy to optimize drug delivery across biological barriers.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diurnal testosterone oscillations gate drug delivery via phase separation of ZO-1 at the blood-testis barrier in mice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月1日

查看全文
  • Zhaoyang Wang,
  • Qihong Wu,
  • Xun Tang,
  • Lu Li,
  • Jingxian Deng,
  • Rufei Huang,
  • Wanqing Lin,
  • Yadong Huang,
  • Yan Yang

摘要

The blood-testis barrier is essential for sperm development but also blocks the delivery of non-hormonal male contraceptives and other germ-cell-targeting therapies. However, how this barrier opens and closes in a controlled manner remains poorly understood. Here we show that the barrier exhibits time-of-day-dependent changes in permeability, allowing drugs to enter selectively during the light phase while remaining sealed during the dark phase. This gating mechanism is driven by daily fluctuations in testosterone. When testosterone rises at night, it activates calcium channels in supporting cells of the testis, leading to dephosphorylation of a key scaffolding protein called zonula occludens-1. This triggers the protein to undergo liquid-liquid phase separation, forming condensates that tighten the barrier. During the day, when testosterone drops, the condensates dissolve and the barrier becomes more permeable. Manipulating this calcium pathway pharmacologically enhances the entry of a contraceptive candidate without causing permanent toxicity. A specific disordered region within zonula occludens-1 is identified as the core driver of this testosterone-responsive condensation. Our study establishes diurnal hormone oscillations as a physiological rheostat for biomolecular condensate formation, offering a chronotherapeutic strategy to optimize drug delivery across biological barriers.